• The Ticker
  • Message Boards
  • Jobs
  • Medtech[y] Shop
  • 
  • 
  • 
  • View
  • ALL
  • Biotech
  • Medical Device
  • Robotic Surgery
  • Medical Device Sales
  • Medtechy Deals
  • Future of Healthcare
  • Healthcare Fraud
  • Hospitals

Join Our Mailing List Today

Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System

Posted in Medical Device by Medtech[y] Staff

March 06, 2020 • 2 min read

ST. LOUIS, March 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today it has received U.S. Food and Drug Administration (FDA) 510(k) clea...

VBI Vaccines Provides Corporate Update, Outlook for 2020, and Year-End 2019 Financial Results

Posted in Biotech by Medtech[y] Staff

March 05, 2020 • 2 min read

CAMBRIDGE, Mass.--(BUSINESS WIRE)--$VBIV--VBI Vaccines Inc. (Nasdaq: VBIV)(VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today provided a corporate update, its outlook f...

Aerin Medical Announces FDA Clearance and U.S. Launch of Innovative Nonsurgical Procedure for Chronic Rhinitis

Posted in Medical Device by Medtech[y] Staff

March 05, 2020 • 2 min read

AUSTIN, Texas--(BUSINESS WIRE)--Aerin Medical Inc., a company focused on minimally invasive solutions for chronic nasal conditions, today announced U.S. Food and Drug Administration (FDA) clearance and U.S. launch of the company’s second product, the...

Auris Medical Provides Update on Ongoing Clinical Trials with Intranasal Betahistine

Posted in Biotech by Medtech[y] Staff

March 05, 2020 • 2 min read

Hamilton, Bermuda, March 5, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today provided...

SCYNEXIS Announces Preclinical Data on Ibrexafungerp and Azoles against Aspergillus Presented at the 9th Advances Against Aspergillosis and Mucormycosis Conference

Posted in Biotech by Medtech[y] Staff

March 05, 2020 • 2 min read

JERSEY CITY, N.J., March 05, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that data from a pr...

Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online

Posted in Medical Device by Medtech[y] Staff

March 03, 2020 • 2 min read

VANCOUVER, March 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and minimally invas...

Unum Therapeutics Implements Strategic Restructuring to Prioritize Efforts on BOXR1030 for the Treatment of Solid Tumor Cancers

Posted in Biotech by Medtech[y] Staff

March 02, 2020 • 2 min read

CAMBRIDGE, Mass., March 02, 2020 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative cell therapies for solid tumors, today announced plans to prioritize resources towards advancing it...

La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2019

Posted in Biotech by Medtech[y] Staff

March 02, 2020 • 2 min read

SAN DIEGO, March 02, 2020 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseas...

Predictive Oncology Provides Acquisition Update, Stresses Importance of AI in New Anti-Cancers, Anti-Virals and Vaccines

Posted in Biotech by Medtech[y] Staff

March 02, 2020 • 2 min read

MINNEAPOLIS, March 02, 2020 (GLOBE NEWSWIRE) -- Amid mounting concern over the impact of the COVID-19 outbreak, caused by the novel coronavirus 2019-nCoV, governments, universities and companies are racing to develop new diagnostics, vaccines and dru...

JAMA Neurology Publishes Results from Positive Phase 3 Trial of EPIDIOLEX (cannabidiol) oral solution in Children with Seizures Associated with Dravet Syndrome

Posted in Biotech by Medtech[y] Staff

March 02, 2020 • 2 min read

CARLSBAD, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsi...

SUBMIT A TIP

Are you aware of fraud occurring at your workplace or previous place of employment?

Speak up, speak out, do the right thing.

REPORT HEALTHCARE FRAUD

TOP BOARD THREADS
  • Amarin EVAPORATE Study Results
    Amarin Message Board board
  • How do I get into Medical Device Sales?
    Medical Sales General Discussion board
  • What are the Best Biotech Stocks?
    Pharma/Biotech General Discussion board
  • FiercePharma's Top Pharma Companies in the World
    Pharma/Biotech Message Board board
  • Baker Brothers Advisors
    Pharma/Biotech General Discussion board
  • Will the FDA Approval Expanded Label for Vascepa?
    Amarin Message Board board
  • Is Amgen Looking to Acquire MannKind
    MannKind Message Board board
  • MedReps.com Jobs
    Medical Sales General Discussion board
  • Zimmer Biomet Layoffs
    Zimmer Biomet Message Board board
  • Medical Device Reps Back in the OR after COVID-19
    Medical Device Sales General Discussion board
  • READ MORE ON THE BOARDS

FEATURED JOBS
  • Medical Affairs Program Specialist
  • VIEW MORE JOBS

  • First Page
  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page
  • Last Page

Developed by medical sales professionals for medical sales professionals.

 •  @medtechy •  medtechy

copyright Medtechy Inc. ⋅ Report A Tip ⋅ Terms of Use ⋅ Privacy Policy ⋅ DMCA Policy ⋅ Removal Policy ⋅ [email protected]